Anticancer effects of marine compounds blocking the nuclear factor kappa B signaling pathway

Mol Biol Rep. 2022 Oct;49(10):9975-9995. doi: 10.1007/s11033-022-07556-1. Epub 2022 Jun 8.

Abstract

The abnormal expression of nuclear factor kappa B (NF-κB) target genes is closely related to the occurrence, metastasis, and invasion of tumor cells and is an inhibitor of their apoptosis. In recent years, the unique biodiversity in the marine environment has aroused great interest. Many studies indicate that some marine compounds exert anticancer effects on most common human tumors by modulating the NF-κB signaling pathway. In this study, 26 marine compounds that reduce cancer cell survival by suppressing the NF-κB signaling pathway were reviewed. They were derived from a wide range of sources, including sponges, fungi, algae and their derivatives or metabolites. These marine compounds exert antitumor effects through the canonical, noncanonical and atypical NF-κB signaling pathways; however, most of their anticancer targets and mechanisms remain unclear, and more research is needed in the future. Our article provides comprehensive information for researchers investigating the bioactivities of marine compounds and developing marine-derived anticancer drugs.

Keywords: Anticancer; Canonical; Marine compounds; Noncanonical and atypical pathways of NF-κB signaling.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents* / pharmacology
  • Apoptosis
  • Humans
  • NF-kappa B* / metabolism
  • Signal Transduction

Substances

  • Antineoplastic Agents
  • NF-kappa B